Roivant Sciences climbs on positive uveitis trial data Oct 21, 2026 10:13AM
Citi Re-Opens 90-Day Upside Catalyst Watch on Roivant Sciences (ROIV) Oct 12, 2026 06:31AM
Roivant Sciences (ROIV) PT Raised to $35 at Citi Feb 10, 2026 06:13AM
Roivant Sciences (ROIV) PT Raised to $26 at Citi Nov 10, 2025 03:58PM
Roche to acquire Telavant from Roivant and Pfizer for $7.25 billion Oct 23, 2023 06:25AM


Oct 23, 2023 01:00AM Roche Enters Into a Definitive Agreement to Acquire Telavant Including Rights to Novel TL1A Directed Antibody (RVT-3101) for the Treatment of Inflammatory Bowel Disease From Roivant
Aug 30, 2022 07:00AM Roivant to Participate in September Investor Events
Aug 30, 2022 07:00AM Roivant to Participate in September Investor Events
Oct 1, 2021 08:00AM Roivant Sciences Announces Close of Business Combination with Montes Archimedes Acquisition Corp. and Concurrent PIPE Financing
May 3, 2021 07:01AM Roivant Sciences and Montes Archimedes Acquisition Corp. (MAAC) to Combine and Create Publicly Traded Leader in Biopharma and Health Technology